H.S. Kumbhar et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 146 (2015) 80–87
81
The BF2 chelation enhances the electron-withdrawing property as
well as the -electron delocalization. Hence, these compounds
137.30, 130.92, 129.91, 129.86, 129.46, 128.71, 128.61, 127.03,
123.59, 121.83, 111.99, 86.93, 49.70, 27.11. Mass (EI):
p
show long-wavelength absorptions and high electron affinity
[42]. Emissive solids are highly demanded for various applications,
including photoelectric conversion and OLED [43–45].
C22H18ClNO calculated 347.8 (M+), found 348.6 (M+1).
(Z)-2-(1,1-dimethyl-1H-benzo[e]indol-2(3H)-ylidene)-1-
(4-methoxyphenyl) ethanone (3c)
3c obtained from 1 and 2c (1:1 eq) using same procedure as for
3a.
In the present work, we report the synthesis and photophysical
properties of 1,1,2-trimethyl-1H-benzo[e]indole based boron
complexes bearing b-enaminone ligands, which shows the intense
fluorescence in solvents as well as in solid state with large Stokes
shift. Two methyl groups in 1,1,2-trimethyl-1H-benzo[e]indole
moiety decrease the inter molecular interaction, thereby avoiding
the re-absorption and self-quenching [46–48]. This gives rise to
more spaced packing in the solid state, resulting in solid state
luminescence with the excellent photostability.
Yield (67%). mp (156–158 °C); 1H NMR (300 MHz, CDCl3)
d(ppm): 12.02(s, 1H), 7.99–8.01(m, 3H), 7.84(d, J = 7.8 Hz, 1H),
7.75(d, J = 8.7 Hz), 7.48(t, J = 8.1, 8.4 Hz, 1H), 7.32(t, J = 8.1, 8.1 Hz,
1H), 7.25(d, J = 8.7 Hz, 1H), 6.95(d, J = 8.7 Hz, 2H), 6.16(s.1H),
3.84(s, 3H), 1.73(s, 6H). 13C NMR (CDCl3, 75 MHz) d(ppm):
188.62, 175.19, 162.24, 140.09, 132.80, 130.75, 129.93, 129.786,
129.52, 129.3, 129.08, 126.96, 123.38, 121.85, 113.66, 112.00,
86.95, 55.46, 49.51, 27.33. Mass (EI): C23H21NO2 calculated 343.4
(M+), found 344.7 (M+1).
Experimental
Materials and methods
(Z)-ethyl 4-(2-(1,1-dimethyl-1H-benzo[e]indol-2(3H)-ylidene)acetyl)
benzoate (3d)
3d obtained from 1 and 2d (1:1 eq) using same procedure as for
3a.
All reagents and other chemicals were obtained from commer-
cial suppliers and used without further purification. Nuclear
magnetic resonance spectra were recorded on Bruker 300 MHz or
Varian 300M instruments with TMS as an internal standard.
Fluorescence spectra were performed with a Varian Cary Eclipse
Yield (61%). m.p. (178–180 °C); 1H NMR (300 MHz, CDCl3)
d(ppm): 12.12(s, 1H), 8.13(d, J = 8.4 Hz, 2H), 7.99–8.04(m, 3H),
7.87(d, J = 8.1 Hz, 1H), 7.80(d, J = 8.7 Hz, 1H), 7.52(t, J = 8.4,
8.4 Hz, 1H), 7.37(t, J = 8.1, 8.1 Hz, 1H), 7.3(d, J = 8.4 Hz, 1H),
6.25(s, 1H), 4.41(q, 2H), 1.76(s, 6H), 1.42(s, 3H). 13C NMR (CDCl3,
75 MHz) d(ppm): 188.29, 176.48, 166.25, 143.76, 139.66, 132.54,
131.00, 129.92, 129.68, 129.53, 127.21, 127.08, 123.69, 121.88,
112.06, 87.52, 61.24, 49.80, 27.07, 14.39. Mass (EI): C25H23NO3 cal-
culated 385.5 (M+), found 386.7 (M+1).
fluorescence
spectrofluorometer
at
room
temperature.
Thermogravimetric analysis carried out on the Thermo Q-600
instrument. Electrochemical properties investigated on the CHI
instrument. ESI-MS analysis performed on Varian mass spectrome-
ter. UV–Visible spectra were performed with a Perkin-Elmer
Lamda-25 spectrophotometer at room temperature.
Synthesis of the b-enaminone ligands Compound (3a–3e) and their
boron complexes
(Z)-2-(1,1-dimethyl-1H-benzo[e]indol-2(3H)-ylidene)-1-
(4(dimethylamino) phenyl)ethanone (3e)
3e obtained from 1 and 2e (1:1 eq) using same procedure as for
3a.
1,1,2-Trimethyl-1H-benzo[e]indole (1) was synthesised by
previously reported method by using methyl isopropyl ketone
and 2-naphthylhydrazine [49].
Yield (55%). m.p. (180–182 °C); 1H NMR (300 MHz, CDCl3)
d(ppm): 12.00(s, 1H), 7.97–8.02(m,3H), 7.86(d, J = 8.4 Hz, 1H),
7.76(d, J = 8.4 Hz, 1H), 7.49(t, J = 8.1, 7.8 Hz, 1H), 7.33(t, J = 7.8,
7.8 Hz, 1H), 7.26(d, J = 8.7 Hz, 1H), 6.73(d, J = 9.3 Hz, 2H), 6.20(s,
1H), 3.04(s, 6H), 1.76(s, 6H). 13C NMR (CDCl3, 75 MHz) d(ppm):
188.73, 174.10, 152.55, 140.37, 130.56, 129.90, 129.67, 129.59,
129.19, 128.79, 127.65, 126.83, 123.12, 121.80, 111.99, 111.08,
86.90, 49.29, 40.20, 27.50. Mass (EI): C24H24N2O calculated 356.5
(M+), found 357.7 (M+1).
Synthesis of (Z)-2-(1,1-dimethyl-1H-benzo[e]indol-2(3H)-ylidene)-1-
phenylethanone (3a)
Sodium hydride (60 wt% in oil, 1.6 g, 40 mmol) was added to a
toluene (100 mL) solution of 1,1,2-trimethyl-1H-benzo[e]indole 1
(2.1 g, 10 mmol and ethyl benzoate 2a (1.5 g, 10 mmol) at room
temperature. The solution was refluxed for 1 day. After cooling to
0–5 °C, aq. NH4Cl was added to the reaction mixture and extracted
with ethyl acetate. The extract was dried over MgSO4 and concen-
trated in vacuo. Column chromatography of the residue on silica
gel gave 1 (2.6 g, 72%) as a yellow solid. mp (110–112 °C).
1H NMR (300 MHz, CDCl3) d(ppm): 12.12(s,1H), 8.03(m, 3H),
7.88(d, J = 8.1 Hz, 1H), 7.8(d, J = 8.7 Hz, 1H), 7.5(m, 4H), 7.36(t,
J = 8.1 Hz, 8.1, 1H), 7.30(d, J = 8.4 Hz, 1H), 6.22(s, 1H), 1.77(s, 6H).
13C NMR (CDCl3, 75 MHz) d(ppm): 189.51, 175.78, 140.09,
139.93, 131.18, 130.85, 129.92, 129.81, 129.47, 129.26, 128.41,
127.33, 126.96, 123.98, 121.84, 112.03, 87.33, 49.60, 27.20. Mass
(EI): C22H19NO calculated 313.4(M+), found 314.7(M+1).
Synthesis of 8,8-difluoro-12,12-dimethyl-10-phenyl-
8,12dihydrobenzo[e][1,3,2]oxazaborinino [3,4-a]indol-7-ium-8-uide
(4a)
Compound 3a (626 mg, 2 mmol) was dissolved in dry dichloro-
methane (12 mL), triethylamine (0.5 mL, 4 mmol) and boron
trifluoride diethyl ether complex (1.41 mL, 4 mmol) was added to
the solution and stirred at room temperature for 5 h. Then water
was added to the solution. The solution was extracted with
CH2Cl2. The organic layer was washed with water and dried over
MgSO4. The crude obtained, after evaporation of the solvent, was
purified by silica gel column chromatography to afford compound
4a (580 mg, 81%) as a yellow solid.
(Z)-1-(4-chlorophenyl)-2-(1,1-dimethyl-1H-benzo[e]indol-2(3H)-
ylidene)ethanone (3b)
3b obtained from 1 and 2b (1:1 eq) using same procedure as for
3a.
Yield (84%). m.p. (140–142 °C); 1H NMR (300 MHz, CDCl3)
d(ppm): 12.08(s, 1H enolic), 7.99(d, J = 8.7 Hz, 2H), 7.93(d,
J = 8.4 Hz, 2H), 7.8(d, J = 8.4 Hz, 1H), 7.79(d, J = 8.7 Hz, 1H),
7.51(m, J = 8.4, 1.5 Hz, 2H), 7.43(d, J = 9 Hz, 2H), 7.36(m, J = 8.1,
8.1, 1.2 Hz, 1H), 7.29(d, J = 8.4, 1H), 6.14(s, 1H), 1.75(s, 6H). 13C
NMR (CDCl3, 75 MHz) d(ppm): 187, 176.17, 139.71, 138.38,
Yield (81%) m.p. (252–254 °C); 1H NMR (300 MHz, CDCl3)
d(ppm): 7.91–8.09(m, 6H), 7.47–7.62(m, 6H), 6.48(s, 1H), 1.78(s,
6H). 13C NMR (CDCl3, 75 MHz) d(ppm): 182.78, 172.77, 140.82,
134.48, 133.51, 132.68, 132.50, 130.36, 130.03, 128.86, 128.59,
127.66, 127.24, 125.27, 122.31, 115.79, 87.89, 51.67, 24.27. Mass
(EI): C22H18BF2NO calculated 361.2, found 361.4 (M+).